Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator. | MicrobiomeTrials← Back to trialsNCT07157449
Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator.
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-01-27Est. Completion: 2026-10-31
Enrollment target: 1,000 participants Locations- CHU de Nantes, Nantes, Nantes, France
Other microbiome trials you might be interested in
Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy
Ventricular tachycardia (VT, a potentially fatal condition where the ventricle of the heart beats rapidly) superimposed …
Phoenix, United StatesCompleted Oct 2026
Ventricular Arrhythmia
Background:
Ventricular arrhythmia is an abnormal pulse rhythm that starts in the lower part of the heart (ventricles).…
Atlanta, United StatesCompleted Dec 1, 2026
Ventricular TachycardiaIschemic Cardiomyopathy
Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequen…
Houston, United StatesEst. completion Dec 12, 2027